(19)
(11) EP 3 723 743 A2

(12)

(88) Date of publication A3:
16.01.2020

(43) Date of publication:
21.10.2020 Bulletin 2020/43

(21) Application number: 18915505.4

(22) Date of filing: 13.12.2018
(51) International Patent Classification (IPC): 
A61K 31/138(2006.01)
A61K 31/4985(2006.01)
A61K 31/166(2006.01)
A61K 9/20(2006.01)
A61K 31/519(2006.01)
(86) International application number:
PCT/TR2018/050806
(87) International publication number:
WO 2019/203753 (24.10.2019 Gazette 2019/43)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.12.2017 TR 201720443

(71) Applicant: Montero Gida Sanayi Ve Ticaret Anonim Sirketi
34460 Istanbul (TR)

(72) Inventors:
  • TÜRKYILMAZ, Ali.
    34460 Istanbul (TR)
  • PALATÖKEN, Arzu.
    34398 Istanbul (TR)
  • GÜNER, Dicle.
    34460 Istanbul (TR)

(74) Representative: Mutlu, Aydin 
Invokat Intellectual Property Services Ltd. Kartaltepe Mh. Yildiztepe Sk. No:6-Bakirköy
34145 Istanbul
34145 Istanbul (TR)

   


(54) THE PHARMACEUTICAL COMBINATION COMPRISING DAPOXETINE, PHOSPHODIESTERASE TYPE-5 INHIBITOR AND ANTI-EMETIC AGENT